ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.626,45
1,05%
S&P 500
6.032,38
0,56%
Dow Jones
44.910,65
0,42%
Euro vs US Dollar
1,0578
0,00%
Bitcoin
95.956,78
-0,50%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Pulmonx Corporation (LUNG)

  7. Pulmonx Corporation (LUNG) News

LUNG

Pulmonx (LUNG)

Pulmonx Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:LUNG
DatumZeitQuelleÜberschriftSymbolFirma
27/11/202400h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
22/11/202422h28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LUNGPulmonx Corporation
20/11/202422h05GlobeNewswire Inc.Pulmonx to Present at the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:LUNGPulmonx Corporation
19/11/202415h00Business WirePulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and ProvidersNASDAQ:LUNGPulmonx Corporation
15/11/202401h47Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LUNGPulmonx Corporation
07/11/202422h05GlobeNewswire Inc.Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:LUNGPulmonx Corporation
05/11/202422h05GlobeNewswire Inc.Pulmonx to Present at the Stifel 2024 Healthcare ConferenceNASDAQ:LUNGPulmonx Corporation
01/11/202421h23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LUNGPulmonx Corporation
30/10/202421h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUNGPulmonx Corporation
30/10/202421h05GlobeNewswire Inc.Pulmonx Reports Third Quarter 2024 Financial ResultsNASDAQ:LUNGPulmonx Corporation
21/10/202423h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
17/10/202422h20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LUNGPulmonx Corporation
16/10/202422h05GlobeNewswire Inc.Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024NASDAQ:LUNGPulmonx Corporation
19/09/202400h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
12/09/202422h32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LUNGPulmonx Corporation
09/09/202422h05GlobeNewswire Inc.Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024NASDAQ:LUNGPulmonx Corporation
06/09/202400h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
06/09/202400h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
29/08/202422h05GlobeNewswire Inc.Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth ConferenceNASDAQ:LUNGPulmonx Corporation
23/08/202400h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
22/08/202422h05GlobeNewswire Inc.Pulmonx to Present at the 2024 Wells Fargo Healthcare ConferenceNASDAQ:LUNGPulmonx Corporation
02/08/202422h27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LUNGPulmonx Corporation
31/07/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUNGPulmonx Corporation
31/07/202422h05GlobeNewswire Inc.Pulmonx Reports Second Quarter 2024 Financial ResultsNASDAQ:LUNGPulmonx Corporation
29/07/202422h05GlobeNewswire Inc.Pulmonx to Present at the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:LUNGPulmonx Corporation
10/07/202422h05GlobeNewswire Inc.Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024NASDAQ:LUNGPulmonx Corporation
06/06/202400h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
06/06/202400h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
06/06/202400h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
05/06/202423h59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
 Showing the most relevant articles for your search:NASDAQ:LUNG

Kürzlich von Ihnen besucht

NASDAQ
LUNG
Pulmonx
BIT
UC6W14
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten

BLACK FRIDAY

ADVFN

Seit 25 Jahren im Geschäft 1999-2024

Sparen Sie bis zu 60%* für Euronext Level 2

1 Jahr 40%, 2 Jahre 50% und *3 Jahre 60%

*Über 3 Jahre 1094.04€, jetzt nur noch 437.62€